Skip to main content

Table 4 Adverse events of sunitinib

From: Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

Adverse events

Grade 1–2, n

Grade 3–4, n

n, %

Thrombocytopenia

12

3

15(78.9%)

Thyroid dysfunction

13

1

14(73.7%)

Hand-foot syndrome

12

1

13(68.4%)

Leukocytopenia

9

2

11(57.9%)

Hypertension

9

0

9(47.4%)

Fatigue

8

0

8(42.1%)

Diarrhea

8

0

8(42.1%)

Anorexia

7

0

7(36.8%)

Palpebral edema

6

0

6(31.6%)

Oral mucositis

5

0

5(26.3%)

Hypophosphatemia

3

0

3(15.8%)

Liver dysfunction

1

0

1(5.3%)